Cargando…
Clinical Implications of Physical Function and Resilience in Patients Undergoing Transcatheter Aortic Valve Replacement
BACKGROUND: Gait speed is a reliable measure of physical function and frailty in patients with aortic stenosis undergoing transcatheter aortic valve replacement (TAVR). Slow gait speed pre‐TAVR predicts worse clinical outcomes post‐TAVR. The consequences of improved versus worsened physical function...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7660783/ https://www.ncbi.nlm.nih.gov/pubmed/32856530 http://dx.doi.org/10.1161/JAHA.120.017075 |
_version_ | 1783609080674254848 |
---|---|
author | Goel, Kashish O’Leary, Jared M. Barker, Colin M. Levack, Melissa Rajagopal, Vivek Makkar, Raj R. Bajwa, Tanvir Kleiman, Neal Linke, Axel Kereiakes, Dean J. Waksman, Ron Allocco, Dominic J. Rizik, David G. Reardon, Michael J. Lindman, Brian R. |
author_facet | Goel, Kashish O’Leary, Jared M. Barker, Colin M. Levack, Melissa Rajagopal, Vivek Makkar, Raj R. Bajwa, Tanvir Kleiman, Neal Linke, Axel Kereiakes, Dean J. Waksman, Ron Allocco, Dominic J. Rizik, David G. Reardon, Michael J. Lindman, Brian R. |
author_sort | Goel, Kashish |
collection | PubMed |
description | BACKGROUND: Gait speed is a reliable measure of physical function and frailty in patients with aortic stenosis undergoing transcatheter aortic valve replacement (TAVR). Slow gait speed pre‐TAVR predicts worse clinical outcomes post‐TAVR. The consequences of improved versus worsened physical function post‐TAVR are unknown. METHODS AND RESULTS: The REPRISE III (Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve System–Randomized Clinical Evaluation) trial randomized high/extreme risk patients to receive a mechanically‐expanded or self‐expanding transcatheter heart valve. Of 874 patients who underwent TAVR, 576 with complete data at baseline and 1 year were included in this analysis. Slow gait speed in the 5‐m walk test was defined as <0.83 m/s. A clinically meaningful improvement (≥0.1 m/s) in gait speed 1 year after TAVR occurred in 39% of patients, 35% exhibited no change, and 26% declined (≥0.1 m/s). Among groups defined by baseline/1‐year post‐TAVR gait speeds, 1‐ to 2‐year mortality or hospitalization rates were as follows: 6.6% (normal/normal), 8.0% (slow/normal), 20.9% (normal/slow), and 21.5% (slow/slow). After adjustment, slow gait speed at 1 year (regardless of baseline speed) was associated with a 3.5‐fold increase in death/hospitalization between 1 and 2 years compared with those with normal baseline/1‐year gait speed. Patients whose slow gait speed normalized at 1 year had no increased risk. One‐year, but not baseline, gait speed was associated with death or hospitalization between 1 and 2 years (adjusted hazard ratio, 0.83 per 0.1 m/s faster gait; 95% CI, 0.74–0.93, P=0.001). CONCLUSIONS: Marked heterogeneity exists in the trajectory of physical function after TAVR and this, more than baseline function, has clinical consequences. Identifying and optimizing factors associated with physical resilience after TAVR may improve outcomes. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT02202434. |
format | Online Article Text |
id | pubmed-7660783 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-76607832020-11-17 Clinical Implications of Physical Function and Resilience in Patients Undergoing Transcatheter Aortic Valve Replacement Goel, Kashish O’Leary, Jared M. Barker, Colin M. Levack, Melissa Rajagopal, Vivek Makkar, Raj R. Bajwa, Tanvir Kleiman, Neal Linke, Axel Kereiakes, Dean J. Waksman, Ron Allocco, Dominic J. Rizik, David G. Reardon, Michael J. Lindman, Brian R. J Am Heart Assoc Original Research BACKGROUND: Gait speed is a reliable measure of physical function and frailty in patients with aortic stenosis undergoing transcatheter aortic valve replacement (TAVR). Slow gait speed pre‐TAVR predicts worse clinical outcomes post‐TAVR. The consequences of improved versus worsened physical function post‐TAVR are unknown. METHODS AND RESULTS: The REPRISE III (Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve System–Randomized Clinical Evaluation) trial randomized high/extreme risk patients to receive a mechanically‐expanded or self‐expanding transcatheter heart valve. Of 874 patients who underwent TAVR, 576 with complete data at baseline and 1 year were included in this analysis. Slow gait speed in the 5‐m walk test was defined as <0.83 m/s. A clinically meaningful improvement (≥0.1 m/s) in gait speed 1 year after TAVR occurred in 39% of patients, 35% exhibited no change, and 26% declined (≥0.1 m/s). Among groups defined by baseline/1‐year post‐TAVR gait speeds, 1‐ to 2‐year mortality or hospitalization rates were as follows: 6.6% (normal/normal), 8.0% (slow/normal), 20.9% (normal/slow), and 21.5% (slow/slow). After adjustment, slow gait speed at 1 year (regardless of baseline speed) was associated with a 3.5‐fold increase in death/hospitalization between 1 and 2 years compared with those with normal baseline/1‐year gait speed. Patients whose slow gait speed normalized at 1 year had no increased risk. One‐year, but not baseline, gait speed was associated with death or hospitalization between 1 and 2 years (adjusted hazard ratio, 0.83 per 0.1 m/s faster gait; 95% CI, 0.74–0.93, P=0.001). CONCLUSIONS: Marked heterogeneity exists in the trajectory of physical function after TAVR and this, more than baseline function, has clinical consequences. Identifying and optimizing factors associated with physical resilience after TAVR may improve outcomes. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT02202434. John Wiley and Sons Inc. 2020-08-28 /pmc/articles/PMC7660783/ /pubmed/32856530 http://dx.doi.org/10.1161/JAHA.120.017075 Text en © 2020 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Research Goel, Kashish O’Leary, Jared M. Barker, Colin M. Levack, Melissa Rajagopal, Vivek Makkar, Raj R. Bajwa, Tanvir Kleiman, Neal Linke, Axel Kereiakes, Dean J. Waksman, Ron Allocco, Dominic J. Rizik, David G. Reardon, Michael J. Lindman, Brian R. Clinical Implications of Physical Function and Resilience in Patients Undergoing Transcatheter Aortic Valve Replacement |
title | Clinical Implications of Physical Function and Resilience in Patients Undergoing Transcatheter Aortic Valve Replacement |
title_full | Clinical Implications of Physical Function and Resilience in Patients Undergoing Transcatheter Aortic Valve Replacement |
title_fullStr | Clinical Implications of Physical Function and Resilience in Patients Undergoing Transcatheter Aortic Valve Replacement |
title_full_unstemmed | Clinical Implications of Physical Function and Resilience in Patients Undergoing Transcatheter Aortic Valve Replacement |
title_short | Clinical Implications of Physical Function and Resilience in Patients Undergoing Transcatheter Aortic Valve Replacement |
title_sort | clinical implications of physical function and resilience in patients undergoing transcatheter aortic valve replacement |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7660783/ https://www.ncbi.nlm.nih.gov/pubmed/32856530 http://dx.doi.org/10.1161/JAHA.120.017075 |
work_keys_str_mv | AT goelkashish clinicalimplicationsofphysicalfunctionandresilienceinpatientsundergoingtranscatheteraorticvalvereplacement AT olearyjaredm clinicalimplicationsofphysicalfunctionandresilienceinpatientsundergoingtranscatheteraorticvalvereplacement AT barkercolinm clinicalimplicationsofphysicalfunctionandresilienceinpatientsundergoingtranscatheteraorticvalvereplacement AT levackmelissa clinicalimplicationsofphysicalfunctionandresilienceinpatientsundergoingtranscatheteraorticvalvereplacement AT rajagopalvivek clinicalimplicationsofphysicalfunctionandresilienceinpatientsundergoingtranscatheteraorticvalvereplacement AT makkarrajr clinicalimplicationsofphysicalfunctionandresilienceinpatientsundergoingtranscatheteraorticvalvereplacement AT bajwatanvir clinicalimplicationsofphysicalfunctionandresilienceinpatientsundergoingtranscatheteraorticvalvereplacement AT kleimanneal clinicalimplicationsofphysicalfunctionandresilienceinpatientsundergoingtranscatheteraorticvalvereplacement AT linkeaxel clinicalimplicationsofphysicalfunctionandresilienceinpatientsundergoingtranscatheteraorticvalvereplacement AT kereiakesdeanj clinicalimplicationsofphysicalfunctionandresilienceinpatientsundergoingtranscatheteraorticvalvereplacement AT waksmanron clinicalimplicationsofphysicalfunctionandresilienceinpatientsundergoingtranscatheteraorticvalvereplacement AT alloccodominicj clinicalimplicationsofphysicalfunctionandresilienceinpatientsundergoingtranscatheteraorticvalvereplacement AT rizikdavidg clinicalimplicationsofphysicalfunctionandresilienceinpatientsundergoingtranscatheteraorticvalvereplacement AT reardonmichaelj clinicalimplicationsofphysicalfunctionandresilienceinpatientsundergoingtranscatheteraorticvalvereplacement AT lindmanbrianr clinicalimplicationsofphysicalfunctionandresilienceinpatientsundergoingtranscatheteraorticvalvereplacement |